Effect of MTHFR 1298A→C and MTHFR 677C→T genotypes on total homocysteine, folate, and vitamin B12 plasma concentrations in kidney graft recipients

Journal of the American Society of Nephrology

Volumn 11, Issue 10, 2000, Pages 1918-1925

  Fodinger, M ^a   Buchmayer, H ^a   Heinz, G ^a   Papagiannopoulos, M ^a   Kletzmayr, J ^a   Rasoul Rockenschaub, S ^a   Horl, W H ^a   Sunder Plassmann, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

ALLELE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE CLEARANCE; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY GRAFT; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0033779530     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hyperhomocysteinemia in chronic renal disease
2. Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients
3. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients
4. Hyperhomocysteinaemia: A significant risk factor for cardiovascular disease in renal transplant recipients
5. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients
6. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: A prospective study
7. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
8. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations
9. Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid
10. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
11. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
12. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
13. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
14. Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas
15. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?
16. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
17. American Society of Human Genetics/American College of Medical Genetics Test, and Transfer Committee Working Group: Measurement and use of total plasma homocysteine
18. Prediction of creatinine clearance from serum creatinine
19. Laboratory diagnosis of vitamin B12 and folate deficiency: A guide for the primary care physician
20. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells
21. Methylenetetrahydrofolate-reductase gene C677T variant and kidney-transplant survival
22. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia
23. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B 12 and on the risk of premature atherosclerosis
24. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease
25. Folate-homocysteine interrelations: Potential new markers of folate status
26. Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: Differences between the radioassay and microbiological assays
27. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida